These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2059395)

  • 1. Are angiotensin converting enzyme inhibition and aldosterone antagonism equivalent in hypertensive patients over fifty?
    Plouin PF; Battaglia C; Alhenc-Gélas F; Corvol P
    Am J Hypertens; 1991 Apr; 4(4 Pt 1):356-62. PubMed ID: 2059395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of spironolactone and angiotensin-converting enzyme inhibitor on left ventricular hypertrophy in patients with essential hypertension.
    Sato A; Suzuki Y; Saruta T
    Hypertens Res; 1999 Mar; 22(1):17-22. PubMed ID: 10221346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of vascular changes by renin-angiotensin-aldosterone system in salt-sensitive hypertension.
    Zeng ZH; Luo BH; Gao YJ; Su CJ; He CC; Yi JJ; Li N; Lee RM
    Eur J Pharmacol; 2004 Oct; 503(1-3):129-33. PubMed ID: 15496307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of spironolactone on blood pressure and the renin-angiotensin-aldosterone system in oligo-anuric hemodialysis patients.
    Gross E; Rothstein M; Dombek S; Juknis HI
    Am J Kidney Dis; 2005 Jul; 46(1):94-101. PubMed ID: 15983962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of angiotensin converting enzyme inhibitors in the elderly: the example of perindopril.
    Forette F; McClaran J; Delesalle MC; Hervy MP; Bouchacourt P; Henry-Amar M; Santoni JP
    Clin Exp Hypertens A; 1989; 11 Suppl 2():587-603. PubMed ID: 2691131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose spironolactone, added to long-term ACE inhibitor therapy, reduces blood pressure and urinary albumin excretion in obese patients with hypertensive target organ damage.
    Bomback AS; Muskala P; Bald E; Chwatko G; Nowicki M
    Clin Nephrol; 2009 Dec; 72(6):449-56. PubMed ID: 19954722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldosterone excess or escape: Treating resistant hypertension.
    Ubaid-Girioli S; Adriana de Souza L; Yugar-Toledo JC; Martins LC; Ferreira-Melo S; Coelho OR; Sierra C; Coca A; Pimenta E; Moreno H
    J Clin Hypertens (Greenwich); 2009 May; 11(5):245-52. PubMed ID: 19534021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study.
    Pitt B; Reichek N; Willenbrock R; Zannad F; Phillips RA; Roniker B; Kleiman J; Krause S; Burns D; Williams GH
    Circulation; 2003 Oct; 108(15):1831-8. PubMed ID: 14517164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long term reduction of microalbuminuria after 1 year of angiotensin converting enzyme inhibition by perindopril in hypertensive insulin-treated diabetic patients.
    Brichard SM; Santoni JP; Thomas JR; van de Voorde K; Ketelslegers JM; Lambert AE
    Diabete Metab; 1990; 16(1):30-6. PubMed ID: 2185055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patients.
    Fogari R; Zoppi A; Lazzari P; Preti P; Mugellini A; Corradi L; Lusardi P
    J Cardiovasc Pharmacol; 1998 Oct; 32(4):616-20. PubMed ID: 9781930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effect of combined spironolactone and quinapril treatment on thrombosis and hemostasis in 2K1C hypertensive rats.
    Gromotowicz-Poplawska A; Stankiewicz A; Mikita J; Aleksiejczuk M; Marcinczyk N; Szemraj J; Chabielska E
    J Physiol Pharmacol; 2018 Apr; 69(2):. PubMed ID: 29980144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors.
    Weir MR; Bakris GL; Gross C; Mayo MR; Garza D; Stasiv Y; Yuan J; Berman L; Williams GH
    Kidney Int; 2016 Sep; 90(3):696-704. PubMed ID: 27350174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolving role of aldosterone blockers alone and in combination with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in hypertension management: a review of mechanistic and clinical data.
    Black HR
    Am Heart J; 2004 Apr; 147(4):564-72. PubMed ID: 15077068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
    Furumatsu Y; Nagasawa Y; Tomida K; Mikami S; Kaneko T; Okada N; Tsubakihara Y; Imai E; Shoji T
    Hypertens Res; 2008 Jan; 31(1):59-67. PubMed ID: 18360019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-albuminuric effect of the aldosterone blocker eplerenone in non-diabetic hypertensive patients with albuminuria: a double-blind, randomised, placebo-controlled trial.
    Ando K; Ohtsu H; Uchida S; Kaname S; Arakawa Y; Fujita T;
    Lancet Diabetes Endocrinol; 2014 Dec; 2(12):944-53. PubMed ID: 25466242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: an open-label crossover randomized controlled trial.
    Tylicki L; Rutkowski P; Renke M; Larczyński W; Aleksandrowicz E; Lysiak-Szydlowska W; Rutkowski B
    Am J Kidney Dis; 2008 Sep; 52(3):486-93. PubMed ID: 18423812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term decrease of microalbuminuria after one year of treatment with perindopril in hypertensive diabetic patients].
    Brichard SM; Santoni JP; Thomas JR; Van de Voorde K; Ketelslegers JM; Lambert AE
    Ann Cardiol Angeiol (Paris); 1990 Oct; 39(8):495-9. PubMed ID: 2281920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of perindopril and hydrochlorothiazide alone and in combination on blood pressure and on the renin-angiotensin system in hypertensive subjects.
    Brown CL; Backhouse CI; Grippat JC; Santoni JP
    Eur J Clin Pharmacol; 1990; 39(4):327-32. PubMed ID: 2076713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Melbourne Diabetic Nephropathy Study Group.
    BMJ; 1991 Jan; 302(6770):210-6. PubMed ID: 1998761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term reduction of microalbuminuria after 3 years of angiotensin-converting enzyme inhibition by perindopril in hypertensive insulin-treated diabetic patients.
    Hermans MP; Brichard SM; Colin I; Borgies P; Ketelslegers JM; Lambert AE
    Am J Med; 1992 Apr; 92(4B):102S-107S. PubMed ID: 1580274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.